Abbott Moves One Way in Cardiovascular Devices, Another in Orthopedics, To Get To the Same Place
Executive Summary
Abbott Laboratories broke into the spinal market with its acquisition of Spinal Concepts, and expanded its interventional cardiology product line by acquiring Jomed's coronary and peripheral interventional product lines. Both deals reflect the increasing convergence in medical devices of drug and device therapies.
You may also be interested in...
Abbott Ventures: Extending Horizons in Abbott's Device Pipeline
Corporate venture investing has become an increasingly important source of capital as traditional venture firms remained squeezed. In devices, the latest entrant into the field is Abbott Ventures, which sees itself as an extension of Abbott's internal efforts to build its device pipeline, favoring mid-stage deals in technology and therapeutic areas that fit strategically with Abbott's existing device businesses.
Deal Statistics Quarterly, Q2 2003
In Vivo presents another installment of our quarterly reivew of dealmaking--in this case April-June 2003. Our data come from Windhover's Strategic Transactions Database. We include medical device financings by deal type; diagnostic financings by industry segment; pharma and biotech alliances by therapeutic category and industry segment; pharma and biotech financings by market segment, and pharma and biotech M&A.
Deal Statistics Quarterly, Q2 2003
In Vivo presents another installment of our quarterly reivew of dealmaking--in this case April-June 2003. Our data come from Windhover's Strategic Transactions Database. We include medical device financings by deal type; diagnostic financings by industry segment; pharma and biotech alliances by therapeutic category and industry segment; pharma and biotech financings by market segment, and pharma and biotech M&A.